financial results

Legacy Housing will release 2025 full-year earnings March 12, 2026, followed by a conference call March 13, offering investors insights into affordable housing market trends.

Destination XL Group will release FY2025 financial results on March 19, 2026, with leadership discussing performance of its DXL and Casual Male XL stores.

Ascentage Pharma will report 2025 full-year unaudited results on March 25, 2026, with dual-language investor webcasts highlighting performance of its approved cancer therapies and clinical pipeline progress.

UCloud Link to report Q4 and full year 2025 results March 18, 2026 before U.S. market open with management conference call at 8:30 a.m. ET.

36Kr Holdings Inc. will report FY2025 unaudited financial results on March 17, 2026, with management conference call at 8:00 a.m. ET and webcast access provided.

Camping World Holdings faces class action lawsuit over alleged false statements about inventory management. Stock fell 25% after Q3 earnings, then 16% after Q4 results; dividend suspended.

IceCure Medical will report 2025 full-year results March 17, 2026, before market open, with a conference call at 11:00 a.m. EDT.

Protara Therapeutics reported $57.4M full-year 2025 loss while unveiling promising 68% response rate for TARA-002 in bladder cancer trial with funding extending to 2028.

Kyntra Bio will report fourth quarter and full year 2025 financial results on March 16, 2026, as the biopharmaceutical company advances its oncology and rare disease pipeline.

3D Systems reports Q4 2025 revenue of $106.3M, up 16% sequentially and exceeding guidance. Full-year net income surges to $29.9M from $255.6M loss in 2024.

$LVLU will report 2025 earnings on March 30, 2026, with investor call at 5 p.m. ET via webcast and conference lines.

Winnebago Industries will report second quarter fiscal 2026 results March 25, with leadership discussing performance via conference call.

$TIGR to report Q4 and full-year 2025 earnings March 19, 2026, with management conference call at 8:00 AM ET same day.

NewLake Capital reports $51.1M full-year revenue and $2.09 AFFO per share, declares $0.43 Q1 2026 dividend amid tenant disruptions.

Johnson Fistel investigates Horizon Technology Finance for potential securities violations following a significant net investment income decline that triggered a 23% stock drop.

Aligos reports $24.2M net loss in 2025, down 82% YoY. Key hepatitis B study enrollment complete; cash runway extends to Q3 2026.

Syra Health ($SYRA) will report fourth-quarter and full-year 2025 financial results on March 12, 2026, before market open.

PPHC to report 2025 results March 23, 2026 after market close with conference call featuring CEO, CFO, and Chief Strategy Officer.

Itafos announces Q4 and full-year 2025 results release on March 18, 2026, with webcast on March 23.

OTC Markets Group reported 13% revenue growth to $125.3M in 2025, with operating income up 19% and diluted EPS reaching $2.58.